EZH2 Promotes Malignant Behaviors via Cell Cycle Dysregulation and Its mRNA Level Associates with Prognosis of Patient with Non-Small Cell Lung Cancer
Figure 5
Probability of survival by EZH2 expression level.
Kaplan- Meier estimation of overall survival, disease-specific survival and disease-free survival by (A) EZH2 expression in tumor tissues relative to adjacent normal lung tissues (EZH2-fold change); and (B) EZH2 expression levels in tumor tissue by itself (dCt_Tumor). The median of each measure was used to dichotomize the patient population.